{"id":"https://openalex.org/W2129508578","doi":"https://doi.org/10.1186/1479-5876-10-28","title":"Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion","display_name":"Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion","publication_year":2012,"publication_date":"2012-02-10","ids":{"openalex":"https://openalex.org/W2129508578","doi":"https://doi.org/10.1186/1479-5876-10-28","mag":"2129508578","pmid":"https://pubmed.ncbi.nlm.nih.gov/22325452","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3306270"},"language":"en","primary_location":{"id":"doi:10.1186/1479-5876-10-28","doi":"https://doi.org/10.1186/1479-5876-10-28","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1479-5876-10-28","pdf_url":"https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/1479-5876-10-28","source":{"id":"https://openalex.org/S142026636","display_name":"Journal of Translational Medicine","issn_l":"1479-5876","issn":["1479-5876"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Translational Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/1479-5876-10-28","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003060935","display_name":"Erika Paige Hamilton","orcid":"https://orcid.org/0000-0002-1911-0336","observed_orcids":["https://orcid.org/0000-0002-1911-0336"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erika Hamilton","raw_affiliation_strings":["Department of Surgery, Division of General Surgery, Duke University Medical Center, Durham, NC, USA. lyerl001@mc.duke.edu","Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Division of General Surgery, Duke University Medical Center, Durham, NC, USA. lyerl001@mc.duke.edu","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112904379","display_name":"Kimberly Blackwell","orcid":"https://orcid.org/0009-0009-3644-861X","observed_orcids":["https://orcid.org/0009-0009-3644-861X"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kimberly Blackwell","raw_affiliation_strings":["Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA","Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA","institution_ids":["https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108440129","display_name":"Amy C. Hobeika","orcid":"https://orcid.org/0009-0007-5701-9027","observed_orcids":["https://orcid.org/0009-0007-5701-9027"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy C Hobeika","raw_affiliation_strings":["Department of Surgery, Division of General Surgery, Duke University Medical Center, Durham, NC, USA","Department of Surgery, Division of General Surgery, Duke University Medical Center, Durham, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Division of General Surgery, Duke University Medical Center, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Department of Surgery, Division of General Surgery, Duke University Medical Center, Durham, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104348991","display_name":"Timothy M. Clay","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Timothy M Clay","raw_affiliation_strings":["GlaxoSmithKline Biologicals, Rixensart, Belgium","GlaxoSmithKline#N#          Biologicals, Rixensart, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]},{"raw_affiliation_string":"GlaxoSmithKline#N#          Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111691313","display_name":"Gloria Broadwater","orcid":"https://orcid.org/0000-0002-9845-7564","observed_orcids":["https://orcid.org/0000-0002-9845-7564"]},"institutions":[{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gloria Broadwater","raw_affiliation_strings":["Cancer Statistical Center, Duke Cancer Institute, Durham, NC, USA","Cancer Statistical Center, Duke Cancer Institute, Durham, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Statistical Center, Duke Cancer Institute, Durham, NC, USA","institution_ids":["https://openalex.org/I4390039326"]},{"raw_affiliation_string":"Cancer Statistical Center, Duke Cancer Institute, Durham, USA","institution_ids":["https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034868635","display_name":"Xiu-Rong Ren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiu-Rong Ren","raw_affiliation_strings":["Department of Medicine, Division of Gastroenterology, Duke University Medical Center, Durham, NC, USA","Department of Medicine Division of Gastroenterology, Duke University Medical Center, Durham, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Gastroenterology, Duke University Medical Center, Durham, NC, USA","institution_ids":["https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Department of Medicine Division of Gastroenterology, Duke University Medical Center, Durham, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100780046","display_name":"Wei Chen","orcid":"https://orcid.org/0000-0002-9934-4000","observed_orcids":["https://orcid.org/0000-0002-9934-4000"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wei Chen","raw_affiliation_strings":["Department of Medicine, Division of Gastroenterology, Duke University Medical Center, Durham, NC, USA","Department of Medicine Division of Gastroenterology, Duke University Medical Center, Durham, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Gastroenterology, Duke University Medical Center, Durham, NC, USA","institution_ids":["https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Department of Medicine Division of Gastroenterology, Duke University Medical Center, Durham, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108369768","display_name":"Henry J. Castro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Henry Castro","raw_affiliation_strings":["GlaxoSmithKline Biologicals, Rixensart, Belgium","GlaxoSmithKline#N#          Biologicals, Rixensart, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]},{"raw_affiliation_string":"GlaxoSmithKline#N#          Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006704059","display_name":"Fr\u00e9d\u00e9ric Fran\u00e7ois Lehmann","orcid":"https://orcid.org/0000-0002-6409-1904","observed_orcids":["https://orcid.org/0000-0002-6409-1904"]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Frederic Lehmann","raw_affiliation_strings":["GlaxoSmithKline Biologicals, Rixensart, Belgium","GlaxoSmithKline#N#          Biologicals, Rixensart, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]},{"raw_affiliation_string":"GlaxoSmithKline#N#          Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020602283","display_name":"Neil L. Spector","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neil Spector","raw_affiliation_strings":["Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA","Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA","institution_ids":["https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008662619","display_name":"Jun-Ping Wei","orcid":"https://orcid.org/0000-0001-6311-6033","observed_orcids":["https://orcid.org/0000-0001-6311-6033"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Junping Wei","raw_affiliation_strings":["Department of Surgery, Division of Surgical Sciences, Duke University Medical Center, Durham, NC, USA","Department of Surgery, Division of Surgical Sciences, Duke University Medical Center, Durham, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Division of Surgical Sciences, Duke University Medical Center, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Department of Surgery, Division of Surgical Sciences, Duke University Medical Center, Durham, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077597600","display_name":"Takuya Osada","orcid":"https://orcid.org/0000-0003-1424-5001","observed_orcids":["https://orcid.org/0000-0003-1424-5001"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Takuya Osada","raw_affiliation_strings":["Department of Surgery, Division of Surgical Sciences, Duke University Medical Center, Durham, NC, USA","Department of Surgery, Division of Surgical Sciences, Duke University Medical Center, Durham, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Division of Surgical Sciences, Duke University Medical Center, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Department of Surgery, Division of Surgical Sciences, Duke University Medical Center, Durham, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012804507","display_name":"Herbert Kim Lyerly","orcid":"https://orcid.org/0000-0002-0063-4770","observed_orcids":["https://orcid.org/0000-0002-0063-4770"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"H Kim Lyerly","raw_affiliation_strings":["Department of Surgery, Division of General Surgery, Duke University Medical Center, Durham, NC, USA","Department of Surgery, Division of General Surgery, Duke University Medical Center, Durham, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Division of General Surgery, Duke University Medical Center, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Department of Surgery, Division of General Surgery, Duke University Medical Center, Durham, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"last","author":{"id":null,"display_name":"Michael A Morse","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael A Morse","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5012804507"],"corresponding_institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":{"value":3890,"currency":"USD","value_usd":3890},"fwci":5.3997,"has_fulltext":true,"cited_by_count":98,"citation_normalized_percentile":{"value":0.96907253,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"10","issue":"1","first_page":"28","last_page":"28"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.8970000147819519},{"id":"https://openalex.org/keywords/lapatinib","display_name":"lapatinib","score":0.847000002861023},{"id":"https://openalex.org/keywords/trastuzumab-refractory-disease","display_name":"trastuzumab-refractory disease","score":0.921999990940094},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.828000009059906},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.4169999957084656},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5149999856948853},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7369999885559082}],"concepts":[{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.9459792971611023},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.84424889087677},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.8231576681137085},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.542975902557373},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4693259596824646},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4546218514442444},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.4338217079639435},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.43064814805984497},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.4230445623397827},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.41557663679122925},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38926175236701965},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38696569204330444},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38404595851898193},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3543602228164673},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3365582525730133}],"mesh":[{"descriptor_ui":"D000077341","descriptor_name":"Lapatinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000917","descriptor_name":"Antibody Formation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000917","descriptor_name":"Antibody Formation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000939","descriptor_name":"Epitopes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003710","descriptor_name":"Demography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014611","descriptor_name":"Vaccination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017434","descriptor_name":"Protein Structure, Tertiary","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1186/1479-5876-10-28","doi":"https://doi.org/10.1186/1479-5876-10-28","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1479-5876-10-28","pdf_url":"https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/1479-5876-10-28","source":{"id":"https://openalex.org/S142026636","display_name":"Journal of Translational Medicine","issn_l":"1479-5876","issn":["1479-5876"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Translational Medicine","raw_type":"journal-article"},{"id":"pmid:22325452","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22325452","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of translational medicine","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:pubmedcentral.nih.gov:3306270","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3306270/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Transl Med","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:6ab59a80f174481d914e24be25e2f19c","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/6ab59a80f174481d914e24be25e2f19c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Translational Medicine, Vol 10, Iss 1, p 28 (2012)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/1479-5876-10-28","doi":"https://doi.org/10.1186/1479-5876-10-28","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1479-5876-10-28","pdf_url":"https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/1479-5876-10-28","source":{"id":"https://openalex.org/S142026636","display_name":"Journal of Translational Medicine","issn_l":"1479-5876","issn":["1479-5876"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Translational Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G264200489","display_name":"RAPID TRANSLATION OF A NOVEL AND POTENT VACCINE IN HER2+ METASTATIC BREAST CANCER PATIENTS","funder_award_id":"W81XWH0610585","funder_id":"https://openalex.org/F4320306078","funder_display_name":"U.S. Department of Defense"},{"id":"https://openalex.org/G4119534169","display_name":null,"funder_award_id":"W81XWH","funder_id":"https://openalex.org/F4320306078","funder_display_name":"U.S. Department of Defense"}],"funders":[{"id":"https://openalex.org/F4320306078","display_name":"U.S. Department of Defense","ror":"https://ror.org/0447fe631"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2129508578.pdf","grobid_xml":"https://content.openalex.org/works/W2129508578.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1587782817","https://openalex.org/W1772131958","https://openalex.org/W1823881321","https://openalex.org/W1965536515","https://openalex.org/W1969653304","https://openalex.org/W1979563875","https://openalex.org/W1982729445","https://openalex.org/W1984568502","https://openalex.org/W2009648532","https://openalex.org/W2019104791","https://openalex.org/W2031000957","https://openalex.org/W2034625094","https://openalex.org/W2034885195","https://openalex.org/W2059854292","https://openalex.org/W2080518844","https://openalex.org/W2090648424","https://openalex.org/W2091463916","https://openalex.org/W2097947269","https://openalex.org/W2101824720","https://openalex.org/W2102143045","https://openalex.org/W2105871790","https://openalex.org/W2109601337","https://openalex.org/W2110444464","https://openalex.org/W2117342140","https://openalex.org/W2121190313","https://openalex.org/W2121198752","https://openalex.org/W2121517849","https://openalex.org/W2121625674","https://openalex.org/W2125954922","https://openalex.org/W2128564429","https://openalex.org/W2171914135","https://openalex.org/W2281858625","https://openalex.org/W2318605753","https://openalex.org/W4232529261"],"related_works":["https://openalex.org/W2170472397","https://openalex.org/W2090648424","https://openalex.org/W2121198752","https://openalex.org/W2297643985","https://openalex.org/W2334682805","https://openalex.org/W2329546795","https://openalex.org/W2240809995","https://openalex.org/W4377093012","https://openalex.org/W2591201173","https://openalex.org/W2097947269"],"abstract_inverted_index":{"BACKGROUND:":[0],"Patients":[1],"with":[2,42,64,73,79,100,131,172,198,204,211,233],"HER2-overexpressing":[3,76,212],"metastatic":[4],"breast":[5,77,213],"cancer,":[6],"despite":[7],"initially":[8],"benefiting":[9],"from":[10],"the":[11,16,51,93,101,173,222,226],"monoclonal":[12],"antibody":[13,31,118,135],"trastuzumab":[14],"and":[15,55,89,108,119,202],"EGFR/HER2":[17],"tyrosine":[18],"kinase":[19],"inhibitor":[20],"lapatinib,":[21],"will":[22],"eventually":[23],"have":[24],"progressive":[25],"disease.":[26],"HER2-based":[27,59],"vaccines":[28,231],"induce":[29],"polyclonal":[30],"responses":[32,122],"against":[33],"HER2":[34,98,160,230],"that":[35],"demonstrate":[36],"enhanced":[37],"anti-tumor":[38],"activity":[39,56,224],"when":[40,62],"combined":[41,63,99,197],"lapatinib":[43,199,234],"in":[44,138,147,159,209],"murine":[45],"models.":[46],"We":[47,67],"wished":[48],"to":[49,167,179,216,220],"test":[50],"clinical":[52],"safety,":[53],"immunogenicity,":[54],"of":[57,85,92,97,152,175,181,225],"a":[58,81,90],"cancer":[60,78],"vaccine,":[61],"lapatinib.":[65],"METHODS:":[66],"immunized":[68],"women":[69],"(n":[70],"=":[71],"12)":[72],"metastatic,":[74],"trastuzumab-refractory,":[75],"dHER2,":[80],"recombinant":[82],"protein":[83],"consisting":[84],"extracellular":[86],"domain":[87,95],"(ECD)":[88],"portion":[91],"intracellular":[94],"(ICD)":[96],"adjuvant":[102],"AS15,":[103],"containing":[104],"MPL,":[105],"QS21,":[106],"CpG":[107],"liposome.":[109],"Lapatinib":[110],"(1250":[111],"mg/day)":[112],"was":[113,128,136,169,190,200],"administered":[114],"concurrently.":[115],"Peripheral":[116],"blood":[117],"T":[120,143],"cell":[121],"were":[123,145],"measured.":[124],"RESULTS:":[125],"This":[126],"regimen":[127],"well":[129],"tolerated,":[130],"no":[132],"cardiotoxicity.":[133],"Anti-HER2-specific":[134],"induced":[137,228],"all":[139],"patients":[140,176],"whereas":[141],"HER2-specific":[142],"cells":[144],"detected":[146],"one":[148],"patient.":[149],"Preliminary":[150],"analyses":[151],"patient":[153],"serum":[154],"demonstrated":[155],"downstream":[156],"signaling":[157],"inhibition":[158],"expressing":[161],"tumor":[162],"cells.":[163],"The":[164],"median":[165],"time":[166],"progression":[168],"55":[170],"days,":[171],"majority":[174],"progressing":[177],"prior":[178],"induction":[180],"peak":[182],"anti-HER2":[183],"immune":[184],"responses;":[185],"however,":[186],"300-day":[187],"overall":[188],"survival":[189,208],"92%":[191],"(95%":[192],"CI:":[193],"77-100%).":[194],"CONCLUSIONS:":[195],"dHER2":[196],"safe":[201],"immunogenic":[203],"promising":[205],"long":[206],"term":[207],"those":[210],"cancers":[214],"refractory":[215],"trastuzumab.":[217],"Further":[218],"studies":[219],"define":[221],"anticancer":[223],"antibodies":[227],"by":[229],"along":[232],"are":[235],"underway.":[236],"TRIAL":[237],"REGISTRY:":[238],"ClinicalTrials.gov":[239],"NCT00952692.":[240]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2016-06-24T00:00:00"}